The Dunedin Pace of Aging Epigenetic Clock Predicts Mortality Better than Simple Clinical Measures
The Dunedin Pace of Aging (DunedinPACE) epigenetic clock has been shown to predict mortality more effectively than traditional clinical measures, according to a new study leveraging data from the Berlin Aging Study II. Researchers analyzed various biomarkers, including inflammatory, physiological, and functional measures, to assess their predictive power regarding all-cause and cause-specific mortality. The findings reveal that while the DunedinPACE clock stands out as the strongest predictor, its accuracy is enhanced when combined with select clinical measures such as hand grip strength, interleukin-6 levels, and standing balance.
This study underscores the growing importance of epigenetic clocks in aging research, particularly in their potential to refine mortality predictions beyond conventional biomarkers. The results suggest that incorporating epigenetic measures into clinical assessments could lead to more accurate prognostic tools for aging populations.
For longevity professionals, the key takeaway is the validation of the DunedinPACE clock as a critical component in mortality prediction, highlighting the need for integrating epigenetic insights into healthspan and aging-related interventions.